Back to search

Article

Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALS

2025-03-10

Abstract excerpt

Amyotrophic lateral sclerosis (ALS) is characterised by motor neuron (MN) death; however, astrocytes play a key role in disease pathogenesis. Developments in the field of artificial intelligence (AI) have the potential to impact drug discovery in multiple ways, including the rapid identification of drug repurposing candidates. A combination of natural language processing and deep learning algorithms was used to ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c862551e-8a08-56ed-bef3-5cbb349c9ff1
DOI
10.1101/2025.03.06.641147
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALSDOI 10.1101/2025.03.06.641147
Select a neighboring publication to make it the new centre.